New shot takes on botox for Post-Stroke arm tightness
NCT ID NCT07292025
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tested a new drug called JTM201 against Botox in 30 adults who had a stroke at least 6 months ago and still have muscle stiffness in their arm. The goal was to see if JTM201 is safe and can reduce spasticity, making daily tasks like dressing and hygiene easier. The study is already completed, and results will show how it compares to the standard treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- JTM201 (a botulinum toxin type A injection, similar to Botox)
- What this could lead to
- If it works, JTM201 could offer a new option to ease muscle stiffness in the arm after a stroke, improving daily function.
- What could go wrong
- This is a very early Phase 1 trial with only 30 people, so results may not apply widely. It compares JTM201 to Botox, so it may not prove better than existing treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UPPER LIMB SPASTICITY POST-STROKE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul Boramae Hospital
Seoul, South Korea